VR and relaxation techniques tested to calm heart patients
NCT ID NCT06215066
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether virtual reality (VR) or modified progressive muscle relaxation (MPMR) can reduce anxiety and improve attention in 158 heart patients in a cardiac care unit. Patients used VR goggles to watch calming 3D nature scenes or practiced relaxing specific muscle groups while breathing deeply. Researchers measured changes in heart rate, blood pressure, and anxiety levels to see which method worked better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality and modified progressive muscle relaxation
- What this could lead to
- If effective, these techniques could provide simple, non-drug ways to help heart patients feel calmer and more focused during hospital stays.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not apply broadly. The interventions are short-term and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
158 people
The number who actually took part.
- Started
-
Apr 2025
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Admitted to CCU for at least 3 days after stability. * Patients who are conscious and stable condition and all of whom exhibited varying levels of anxiety. Exclusion Criteria: \- Patients with a history of neurological impairments such as motor, visual, and auditory disabilities and psychological disorders.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiac care unit of Smouha Hospital, which is affiliated to Alexandria University, Egypt.
Alexandria, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can video games calm anxious teens?
- Can a group program teach teens to cope before therapy starts?
- Could a Patient's playlist take the sting out of nerve testing?
- Three spanish group sessions put a neuroscience twist on anxiety therapy
- Can a rewired EMDR therapy ease the mental toll of migration?
- Can yoga calm anxious minds and sharpen focus?